contentSlug

type

ContentSlug_ContentQuery

slug

ContentPageContentQuery

content

trendingContent

query ContentSlug_ContentQuery(
  $contentSlug: String!
  $type: [ContentType!]
) {
  ...ContentPageContentQuery_13QmVO
}

fragment CompanyDetails_Content on Content {
  __isContent: __typename
  companies {
    name
    description
    pageUrl
    id
  }
}

fragment CompanyTagList on Company {
  pageUrl
  name
  viewerIsFollowing
}

fragment ContentBasicInfo on Content {
  __isContent: __typename
  id
  type
  title
  lang
  companies {
    ...CompanyTagList
    id
  }
  ...PublishingDetails
  ...Reactions
}

fragment ContentMetadata on Content {
  __isContent: __typename
  type
  title
  lang
  availableLanguages
  pageUrl
  imgUrl
  description
  ... on Video {
    liveTime
    videoUrl
  }
  ... on Webcast {
    liveTime
    videoUrl
  }
}

fragment ContentPageContentQuery_13QmVO on Query {
  content(slug: $contentSlug, type: $type) {
    __typename
    id
    type
    title
    isPremium
    lang
    htmlBody
    companies {
      forum {
        latestPosts {
          ...ForumPosts
        }
      }
      defaultInstrument {
        isin
        id
      }
      id
    }
    slug
    ... on CompanyReport {
      reportUrl
    }
    ... on ThirdPartyCompanyReport {
      reportUrl
    }
    ... on StockExchangeRelease {
      reportUrl
    }
    ...ContentBasicInfo
    ...ContentMetadata
    ...PriceAndRecommendation_Content
    ...CompanyDetails_Content
    ...ReportLink_Content
    ...KeyFigures_Content
  }
  ...TrendingContent_1jQ2Cn
}

fragment ForumPosts on ForumPost {
  text
  likesCount
  url
  author
  postedAt
  authorImgUrl
}

fragment KeyFigures_Content on Content {
  __isContent: __typename
  companies {
    defaultInstrument {
      estimateData {
        modelType
        reportingCurrency
      }
      snapshot {
        transaction {
          date
          actualized {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
          estimates {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
          }
        }
      }
      id
    }
    id
  }
}

fragment PriceAndRecommendation_Content on Content {
  __isContent: __typename
  createdAt
  companies {
    id
    name
    viewerIsFollowing
    defaultInstrument {
      snapshot {
        priceData {
          date
          lastPrice
          tradeCurrency
        }
        transaction {
          date
          recommendation
          targetPrice
        }
        prevTransaction {
          recommendation
        }
      }
      id
    }
  }
}

fragment PublishingDetails on Content {
  __isContent: __typename
  createdAt
  publishers {
    name
    imgUrl
  }
  authors {
    __typename
    id
    name
    slug
    imgUrl
    jobTitle
  }
  ... on Video {
    liveTime
  }
  ... on Webcast {
    liveTime
  }
}

fragment Reactions on Content {
  __isContent: __typename
  id
  reactionGroups {
    reactionType
    reactionsCount
    viewerReacted
  }
}

fragment ReportLink_Content on Content {
  __isContent: __typename
  type
  isPremium
  ... on CompanyReport {
    reportUrl
  }
  ... on ThirdPartyCompanyReport {
    reportUrl
  }
  ... on StockExchangeRelease {
    reportUrl
  }
}

fragment TrendingContent_1jQ2Cn on Query {
  trendingContent(type: ARTICLE) {
    __typename
    id
    title
    lang
    pageUrl
    createdAt
    type
    imgUrl
    companies {
      squareLogoUrl
      id
    }
    authors {
      __typename
      imgUrl
      id
    }
    publishers {
      imgUrl
    }
  }
}


acousort-to-attend-isct-europe-to-expand-its-network-in-the-cell-therapy-space

__typename

title

isPremium

lang

htmlBody

companies

createdAt

publishers

authors

reactionGroups

availableLanguages

pageUrl

imgUrl

description

AcouSort is active within medical technology. The company conducts research and development in a proprietary platform technology that utilises ultrasound to separate and analyse composition of biological cells. The technology is mainly used in the analysis of various cases of cancer as well as sepsis. Part of the research is done together with other stakeholders within field. The company was founded in 2010 and is based in Lund.

AcouSort

On September 4-6, AcouSort will attend ISCT Europe in Gothenburg, Sweden, a conference that gathers an extensive network of cell and gene therapy professionals to address current topics and ...

<div class="mfn-preamble"><p><strong>On September 4-6, AcouSort will attend ISCT Europe in Gothenburg, Sweden, a conference that gathers an extensive network of cell and gene therapy professionals to address current topics and challenges to drive the field forward and break down barriers to enable greater access to patients.</strong></p></div><div class="mfn-body"><p>ISCT Europe offers a great opportunity for AcouSort to connect with global scientists, experts and potential customers, making it an ideal platform for the company to continue developing its network in the field of cell therapy.</p><p>We also present a poster at ISCT Europe together with the Karolinska Institute in Stockholm. The poster is number 43 at the conference and is entitled: <em>Enhancing cell therapy accessibility through bedside formulation:</em> <em>Employing an acoustic-based, automated cell trapping system for washing hPSC-derived RPE cells.</em></p><p>“Attending the ISCT Europe is an important part of our ambition to expand our presence in the very dynamic cell therapy space. We already have a number of collaborations in this field, and we are looking forward to demonstrating how our acoustofluidic technology can be used to improve vital parts in cell therapy production,” says Agnes Michanek, Commercial Director at AcouSort.</p></div><div class="mfn-footer mfn-contacts mfn-699d46db9ccf"><p><strong class="mfn-heading-1">FOR FURTHER INFORMATION ABOUT ACOUSORT, PLEASE CONTACT:</strong><br>Torsten Freltoft, CEO<br>Telephone: +45 2045 0854<br>E-mail: <a rel="noopener" href="mailto:torsten.freltoft@acousort.com">torsten.freltoft@acousort.com</a></p></div><div class="mfn-footer mfn-0fd41d51866e"><p><strong class="mfn-heading-1">ABOUT ACOUSORT</strong><br><em>AcouSort AB (corporate registration number 556824-1037) is an innovative technology company focusing on developing products and solutions for integrated preparation of biological samples. With the help of sound waves, the company's products can separate blood cells, concentrate, purify, and stain cells, exosomes, and bacteria from biological samples. The technology of the company's products is acoustofluidics, where sound waves and microfluidics enable automated handling of samples in a range of application areas, from research on new biomarkers to the development of new diagnostic systems for near-patient testing – so-called Point-of Care (POC) systems. The company's commercialization strategy is based on the already proven business model of providing separation modules to diagnostic system manufacturers for integrated sample preparation as well as to continue the commercialization of the company's research instruments. With the help of the company's products and development of point-of-care tests, new diagnostic systems and treatments are enabled, addressing some of the most challenging disease areas of our time: cancer, infectious diseases, and cardiovascular diseases. AcouSort is listed at Nasdaq First North Growth Market. The company’s Certified Adviser is Carnegie Investment Bank AB (publ).</em></p></div><div class="mfn-footer mfn-attachment mfn-attachment-general"><p><strong class="mfn-heading-1">Attachments</strong><br><a rel="noopener" href="https://storage.mfn.se/87c36007-3357-4db6-ad1a-925094832563/acousort-to-attend-isct-europe-to-expand-its-network-in-the-cell-therapy-space.pdf" class="mfn-generated mfn-primary">AcouSort to attend ISCT Europe to expand its network in the cell therapy space</a></p></div>

Stay up to date with our newsletter